Discover 1,248 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Nashville offers many research opportunities for conditions such as diabetes, cardiovascular disease, and arthritis, giving participants access to innovative treatments and cutting-edge medical care. The city’s leading healthcare institutions are actively recruiting healthy volunteers for paid research studies, as well as individuals seeking trials for specific health concerns.
Filter
2
Filter results
Results: 1,248
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
for
Neoplasms, Prostate
Location: Nashville TN, Rochester MN, East Brunswick NJ,
Sponsor: GlaxoSmithKline
Sex: Male
Age: 18+
Code: NCT06990880
Phase1, Phase2, Recruiting
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
for
Multiple Myeloma
Location: Nashville TN, Cincinnati OH, Indianapolis IN,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06152575
Phase3, Recruiting
A Study of YL242 in Subjects With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Nashville TN, Grand Rapids MI, Sarasota FL
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT07197827
Phase1, Phase2, Recruiting
The APS Phenotyping Study
for
ARDS, Sepsis, Pneumonia
Location: Nashville TN, Cincinnati OH, St Louis MO, Chicago IL,
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 18+
Code: NCT06521502
Recruiting
A Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families
for
Human Papilloma Virus, HPV-Related Carcinoma, Vaccine Refusal,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT06745882
Phase2, Recruiting
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
for
Breast Cancer, TNBC - Triple-Negative Breast Cancer,
Location: Nashville TN, Carbondale IL, Birmingham AL,
Sponsor: Tempus AI
Sex: All
Age: 18 - 70+
Code: NCT07211178
Recruiting
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)